instruction:
In this task, you are given text for US Congressional and California state bills, your task is to generate a summary for this bill.
question:
SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Child Custody Protection Act''.

SEC. 2. TRANSPORTATION OF MINORS IN CIRCUMVENTION OF CERTAIN LAWS 
              RELATING TO ABORTION.

    (a) In General.--Title 18, United States Code, is amended by 
inserting after chapter 117 the following:

 ``CHAPTER 117A--TRANSPORTATION OF MINORS IN CIRCUMVENTION OF CERTAIN 
                       LAWS RELATING TO ABORTION

``Sec
``2431. Transportation of minors in circumvention of certain laws 
                            relating to abortion
``Sec. 2431. Transportation of minors in circumvention of certain laws 
              relating to abortion
    ``(a) Offense.--
            ``(1) Generally.--Except as provided in subsection (b), 
        whoever knowingly transports a minor across a State line, with 
        the intent that such minor obtain an abortion, and thereby in 
        fact abridges the right of a parent under a law requiring 
        parental involvement in a minor's abortion decision, in force 
        in the State where the minor resides, shall be fined under this 
        title or imprisoned not more than one year, or both.
            ``(2) Definition.--For the purposes of this subsection, an 
        abridgement of the right of a parent occurs if an abortion is 
        performed on the minor, in a State other than the State where 
        the minor resides, without the parental consent or 
        notification, or the judicial authorization, that would have 
        been required by that law had the abortion been performed in 
        the State where the minor resides.
    ``(b) Exceptions.--
            ``(1) The prohibition of subsection (a) does not apply if 
        the abortion was necessary to save the life of the minor 
        because her life was endangered by a physical disorder, 
        physical injury, or physical illness, including a life 
        endangering physical condition caused by or arising from the 
        pregnancy itself.
            ``(2) A minor transported in violation of this section, and 
        any parent of that minor, may not be prosecuted or sued for a 
        violation of this section, a conspiracy to violate this 
        section, or an offense under section 2 or 3 based on a 
        violation of this section.
    ``(c) Affirmative Defense.--It is an affirmative defense to a 
prosecution for an offense, or to a civil action, based on a violation 
of this section that the defendant reasonably believed, based on 
information the defendant obtained directly from a parent of the minor 
or other compelling facts, that before the minor obtained the abortion, 
the parental consent or notification, or judicial authorization took 
place that would have been required by the law requiring parental 
involvement in a minor's abortion decision, had the abortion been 
performed in the State where the minor resides.
    ``(d) Civil Action.--Any parent who suffers harm from a violation 
of subsection (a) may obtain appropriate relief in a civil action.
    ``(e) Definitions.--For the purposes of this section--
            ``(1) a `law requiring parental involvement in a minor's 
        abortion decision' means a law--
                    ``(A) requiring, before an abortion is performed on 
                a minor, either--
                            ``(i) the notification to, or consent of, a 
                        parent of that minor; or
                            ``(ii) proceedings in a State court; and
                    ``(B) that does not provide as an alternative to 
                the requirements described in subparagraph (A) 
                notification to or consent of any person or entity who 
                is not described in that subparagraph;
            ``(2) the term `parent' means--
                    ``(A) a parent or guardian;
                    ``(B) a legal custodian; or
                    ``(C) a person standing in loco parentis who has 
                care and control of the minor, and with whom the minor 
                regularly resides, who is designated by the law 
                requiring parental involvement in the minor's abortion 
                decision as a person to whom notification, or from whom 
                consent, is required;
            ``(3) the term `minor' means an individual who is not older 
        than the maximum age requiring parental notification or 
        consent, or proceedings in a State court, under the law 
        requiring parental involvement in a minor's abortion decision; 
        and
            ``(4) the term `State' includes the District of Columbia 
        and any commonwealth, possession, or other territory of the 
        United States.''.
    (b) Clerical Amendment.--The table of chapters for part I of title 
18, United States Code, is amended by inserting after the item relating 
to chapter 117 the following new item:

``117A. Transportation of minors in circumvention of            2431''.
certain laws relating to abortion.
answer:
Child Custody Protection Act - Amends the federal criminal code to prohibit transporting a minor across a state line to obtain an abortion (deems such transporting to be a de facto abridgment of the right of a parent under any law in the minors state of residence that requires parental involvement in the minors abortion decision). Makes an exception for an abortion necessary to save the life of the minor.

Protects from prosecution or civil liability the minor or the minors parents for violations of this Act.

Makes it an affirmative defense to a prosecution or civil action under this Act that a defendant reasonably believed that before the minor obtained the abortion, the required parental consent or notification or judicial authorization took place.

Authorizes any parent who suffers harm from a violation of this Act to seek relief in a civil action. Defines "parent" to include a guardian, legal custodian, or person standing in loco parentis.


question:
SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Health Equity and Accountability 
through Research Act of 2009''.

SEC. 2. NATIONAL INSTITUTE FOR MINORITY HEALTH AND HEALTH DISPARITIES.

    (a) Redesignation.--
            (1) In general.--Title IV of the Public Health Service Act 
        (42 U.S.C. 281 et seq.) is amended--
                    (A) in section 401(b)(24), by striking ``National 
                Center on Minority Health and Health Disparities'' and 
                inserting ``National Institute for Minority Health and 
                Health Disparities''; and
                    (B) in subpart 6 of part E--
                            (i) in the subpart heading, by striking 
                        ``Center'' and inserting ``Institute'';
                            (ii) in the headings of sections 485E and 
                        485H, by striking ``center'' and inserting 
                        ``institute''; and
                            (iii) by striking (other than in section 
                        485E(i)(1)) the term ``Center'' each place it 
                        appears and inserting ``Institute''.
            (2) References.--Any reference in any law, map, regulation, 
        document, paper, or other record of the United States to the 
        National Center on Minority Health and Health Disparities shall 
        be deemed to be a reference to the National Institute for 
        Minority Health and Health Disparities.
    (b) Duties; Authorities; Funding.--Section 485E of the Public 
Health Service Act (42 U.S.C. 287c-31) is amended--
            (1) by amending subsection (e) to read as follows:
    ``(e) Duties of the Director.--
            ``(1) Interagency coordination of minority health and 
        health disparity activities.--With respect to minority health 
        and health disparities, the Director of the Institute shall 
        plan, coordinate, and evaluate research and other activities 
        conducted or supported by the institutes and centers of the 
        National Institutes of Health. In carrying out the preceding 
        sentence, the Director of the Institute shall evaluate the 
        minority health and health disparity activities of each of such 
        institutes and centers and shall provide for the periodic 
        reevaluation of such activities. Such institutes and centers 
        shall be responsible for providing information to the 
        Institute, including data on clinical trials funded or 
        conducted by these institutes and centers.
            ``(2) Consultations.--The Director of the Institute shall 
        carry out this subpart (including developing and revising the 
        plan and budget required by subsection (f) in consultation with 
        the heads of the institutes and centers of the National 
        Institutes of Health, the advisory councils of such institutes 
        and centers, and the advisory council established pursuant to 
        subsection (j).
            ``(3) Coordination of activities.--The Director of the 
        Institute--
                    ``(A) shall act as the primary Federal official 
                with responsibility for coordinating all research and 
                activities conducted or supported by the National 
                Institutes of Health on minority or other health 
                disparities;
                    ``(B) shall represent the health disparities 
                research program of the National Institutes of Health, 
                including the minority health and other health 
                disparities research program, at all relevant executive 
                branch task forces, committees, and planning 
                activities; and
                    ``(C) shall maintain communications with all 
                relevant agencies of the Public Health Service, 
                including the Indian Health Service, and various other 
                departments and agencies of the Federal Government to 
                ensure the timely transmission of information 
                concerning advances in minority health disparities 
                research and other health disparities research among 
                these various agencies for dissemination to affected 
                communities and health care providers.'';
            (2) by amending subsection (f) to read as follows:
    ``(f) Strategic Plan.--
            ``(1) In general.--Subject to the provisions of this 
        section and other applicable law, the Director of the 
        Institute, in consultation with the Director of NIH, the 
        Directors of the other institutes and centers of the National 
        Institutes of Health, and the advisory council established 
        pursuant to subsection (j), shall--
                    ``(A) annually review and revise a strategic plan 
                (referred to in this section as `the plan') and budget 
                for the conduct and support of all minority health 
                disparity research and other health disparity research 
                activities of the institutes and centers of the 
                National Institutes of Health that include time-based 
                targeted objectives with measurable outcomes and assure 
                that the annual review and revision of the plan uses an 
                established trans-National Institutes of Health process 
                subject to timely review, approval, and dissemination;
                    ``(B) ensure that the plan and budget establish 
                priorities among the health disparities research 
                activities that such agencies are authorized to carry 
                out;
                    ``(C) ensure that the plan and budget establish 
                objectives regarding such activities, describe the 
                means for achieving the objectives, and designate the 
                date by which the objectives are expected to be 
                achieved;
                    ``(D) ensure that all amounts appropriated for such 
                activities are expended in accordance with the plan and 
                budget;
                    ``(E) annually submit to Congress a report on the 
                progress made with respect to the plan; and
                    ``(F) create and implement a plan for the systemic 
                review of research activities supported by the National 
                Institutes of Health that are within the mission of 
                both the Institute and other institutes and centers of 
                the National Institutes of Health, including by 
                establishing mechanisms for--
                            ``(i) tracking minority health and health 
                        disparity research conducted within the 
                        institutes and centers assessing the 
                        appropriateness of this research with regard to 
                        the overall goals and objectives of the plan;
                            ``(ii) the early identification of 
                        applications and proposals for grants, 
                        contracts, and cooperative agreements 
                        supporting extramural training, research, and 
                        development, that are submitted to the 
                        institutes and centers that are within the 
                        mission of the Institute;
                            ``(iii) providing the Institute with the 
                        written descriptions and scientific peer review 
                        results of such applications and proposals;
                            ``(iv) enabling the institutes and centers 
                        to consult with the Director of the Institute 
                        prior to final approval of such applications 
                        and proposals; and
                            ``(v) reporting to the Director of the 
                        Institute all such applications and proposals 
                        that are approved for funding by the institutes 
                        and centers.
            ``(2) Certain components of plan and budget.--With respect 
        to health disparities research activities of the agencies of 
        the National Institutes of Health, the Director of the 
        Institute shall ensure that the plan and budget under paragraph 
        (1) provide for--
                    ``(A) basic research and applied research, 
                including research and development with respect to 
                products;
                    ``(B) research that is conducted by the agencies;
                    ``(C) research that is supported by the agencies;
                    ``(D) proposals developed pursuant to solicitations 
                by the agencies and for proposals developed 
                independently of such solicitations; and
                    ``(E) behavioral research and social sciences 
                research, which may include cultural and linguistic 
                research in each of the agencies.
            ``(3) Minority health disparities research.--The plan and 
        budget under paragraph (1) shall include a separate statement 
        of the plan and budget for minority health disparities 
        research.'';
            (3) by amending subsection (h) to read as follows:
    ``(h) Research Endowments.--
            ``(1) In general.--The Director of the Institute shall 
        carry out a program to facilitate minority health and health 
        disparities research and other health disparities research by 
        providing research endowments at--
                    ``(A) centers of excellence under section 736; and
                    ``(B) centers of excellence under section 485F.
            ``(2) Eligibility.--The Director of the Institute shall 
        provide for a research endowment under paragraph (1) only if 
        the institution involved meets the following conditions:
                    ``(A) The institution does not have an endowment 
                that is worth in excess of an amount equal to 50 
                percent of the national average of endowment funds at 
                institutions that conduct similar biomedical research 
                or training of health professionals.
                    ``(B) The application of the institution under 
                paragraph (1) regarding a research endowment has been 
                recommended pursuant to technical and scientific peer 
                review and has been approved by the advisory council 
                established pursuant to subsection (j).
                    ``(C) The institution at any time was deemed to be 
                eligible to receive a grant under section 736 and at 
                any time received a research endowment under paragraph 
                (1).''; and
            (4) by adding at the end the following:
    ``(k) Funding.--
            ``(1) Full funding budget.--
                    ``(A) In general.--With respect to a fiscal year, 
                the Director of the Institute shall prepare and submit 
                directly to the President, for review and transmittal 
                to Congress, a budget estimate for carrying out the 
                plan for the fiscal year, after reasonable opportunity 
                for comment (but without change) by the Secretary, the 
                Director of the National Institutes of Health, the 
                directors of the other institutes and centers of the 
                National Institutes of Health, and the advisory council 
                established pursuant to subsection (j). The budget 
                estimate shall include an estimate of the number and 
                type of personnel needs for the Institute.
                    ``(B) Amounts necessary.--The budget estimate 
                submitted under subparagraph (A) shall estimate the 
                amounts necessary for the institutes and centers of the 
                National Institutes of Health to carry out all minority 
                health and health disparities activities determined by 
                the Director of the Institute to be appropriate, 
                without regard to the probability that such amounts 
                will be appropriated.
            ``(2) Alternate budgets.--
                    ``(A) In general.--With respect to a fiscal year, 
                the Director of the Institute shall prepare and submit 
                to the Secretary and the Director of the National 
                Institutes of Health the budget estimates described in 
                subparagraph (B) for carrying out the plan for the 
                fiscal year. The Secretary and such Director shall 
                consider each of such estimates in making 
                recommendations to the President regarding a budget for 
                the plan for such year.
                    ``(B) Description.--With respect to the fiscal year 
                involved, the budget estimates referred to in 
                subparagraph (A) for the plan are as follows:
                            ``(i) The budget estimate submitted under 
                        paragraph (1).
                            ``(ii) A budget estimate developed on the 
                        assumption that the amounts appropriated will 
                        be sufficient only for--
                                    ``(I) continuing the conduct by the 
                                institutes and centers of the National 
                                Institutes of Health of existing 
                                minority health and health disparity 
                                activities (if approved for 
                                continuation), and continuing the 
                                support of such activities by the 
                                institutes and centers in the case of 
                                projects or programs for which the 
                                institutes or centers have made a 
                                commitment of continued support; and
                                    ``(II) carrying out activities that 
                                are in addition to activities specified 
                                in subclause (I), only for which the 
                                Director determines there is the most 
                                substantial need.
                            ``(iii) Such other budget estimates as the 
                        Director of the Institute determines to be 
                        appropriate.
    ``(l) Authorization of Appropriations.--There are authorized to be 
appropriated $1,000,000,000 for fiscal year 2010 and such sums as may 
be necessary for each of fiscal years 2011 through 2014, to carry out 
this section.''.
answer:
Health Equity and Accountability through Research Act of 2009 - Amends the Public Health Service Act to rename the National Center on Minority Health and Health Disparities as the National Institute for Minority Health and Health Disparities. Revises and expands the duties of the Director of such Institute relating to coordination of research activities conducted by the National Institute of Health (NIH) and review of a strategic plan and budget for minority health disparity research.


question:
SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Liver Research Enhancement Act''.

SEC. 2. FINDINGS.

    The Congress finds as follows:
            (1) An estimated 25,000,000 people in the United States are 
        affected by a liver or liver-related disease.
            (2) In excess of $5,500,000,000 is spent annually to 
        provide medical care for people in the United States with liver 
        disease.
            (3) There are over 4,000,000 people in the United States 
        who are or have been infected with hepatitis C, 2,700,000 of 
        whom are chronically infected.
            (4) Due to limited research, current treatments for 
        hepatitis C are effective in fewer than 50 percent of the 
        cases.
            (5) A vaccine has not been developed for hepatitis C.
            (6) There are 8,000 to 10,000 deaths each year due to 
        hepatitis C, and the annual death total is projected to 
        increase to 30,000 each year absent increased public health and 
        research interventions.
            (7) Chronic infection with hepatitis B or C is associated 
        with an increased incidence of primary liver cancer, once a 
        rare malignancy in the United States.
            (8) There are 1,250,000 people in the United States who 
        have been infected with hepatitis B.
            (9) Up to 15 percent of Asian and Pacific-Islander 
        Americans are chronically infected with hepatitis B.
            (10) Fifteen out of every 100,000 people in the United 
        States are affected by a chronic, life-threatening disease 
        known as primary biliary cirrhosis (PBC), and 95 percent of 
        those affected are women.
            (11) There is an emerging obesity-related chronic liver 
        disease, nonalcoholic fatty liver disease (NAFLD), which may 
        affect as many as 1 in every 4 adults over the age of 18.
            (12) There are 15,000 children hospitalized in the United 
        States each year due to liver disease.
            (13) The only option for many individuals with liver 
        disease is a liver transplant.
            (14) There are over 17,500 people in the United States on 
        the waiting list for a liver transplant, but because of the 
        limited supply of livers available for transplantation only 
        approximately 5,100 transplants are performed each year.
            (15) There are 1,300 people in the United States who die 
        each year waiting for a liver transplant, and that number is 
        expected to increase.
            (16) To address the public health threat posed by liver 
        disease, there is a need for the establishment of a National 
        Center on Liver Disease Research to provide dedicated 
        scientific leadership, to create a research action plan, and to 
        ensure the funding of the scientific opportunities identified 
        by the plan.

SEC. 3. NATIONAL CENTER ON LIVER DISEASE RESEARCH.

    Subpart 3 of part C of title IV of the Public Health Service Act 
(42 U.S.C. 285c, et seq.) is amended by adding at the end the 
following:

              ``national center on liver disease research

    ``Sec. 434B. (a) Establishment.--There is established the National 
Center on Liver Disease Research (hereafter in this section referred to 
as the `Center') in the National Institute of Diabetes and Digestive 
and Kidney Diseases.
    ``(b) Director.--The Center shall be headed by a Director, who 
shall be appointed by the Director of the Institute, in consultation 
with the Director of NIH, from among individuals with the highest 
scientific credentials. The Director of the Center shall report 
directly to the Director of the Institute.
    ``(c) Duties.--To ensure the development of increased understanding 
of and better treatments and cures for liver diseases through a 
dedicated scientific leadership and an adequate allocation of 
resources, the Director shall--
            ``(1) assist the Liver Disease Research Advisory Board to 
        develop the Liver Disease Research Action Plan; and
            ``(2) encourage and coordinate the implementation of the 
        Plan by the national research institutes, including by issuing 
        research solicitations and by using all other available 
        mechanisms.
    ``(d) Liver Disease Research Advisory Board.--
            ``(1) Establishment.--Not later than 90 days after the date 
        of the enactment of this Act, the Director of NIH shall 
        establish a board to be known as the Liver Disease Research 
        Advisory Board (hereafter in this section referred to as the 
        ``Advisory Board'').
            ``(2) Duties.--The Advisory Board shall advise and assist 
        the Director of the Center concerning matters relating to liver 
        disease research, including by developing and revising the 
        Liver Disease Research Action Plan in accordance with 
        subsection (e).
            ``(3) Voting members.--The Advisory Board shall be composed 
        of 18 voting members appointed by the Director of NIH, in 
        consultation with the Director of the Institute, of whom 12 
        shall be eminent scientists and 6 shall be lay persons. The 
        Director of NIH, in consultation with the Director of the 
        Institute, shall select 1 of the members to serve as the Chair 
        of the Advisory Board.
            ``(4) Ex officio members.--The Director of NIH shall 
        appoint each director of a national research institute that 
        funds liver disease research to serve as a nonvoting, ex 
        officio member of the Advisory Board. The Director of NIH shall 
        invite 1 representative of the Centers for Disease Prevention 
        and Control, 1 representative of the Food and Drug 
        Administration, and 1 representative of the Department of 
        Veterans Affairs to serve as such a member. Each ex officio 
        member of the Advisory Board may appoint an individual to serve 
        as that member's representative on the Advisory Board.
    ``(e) Liver Disease Research Action Plan.--
            ``(1) Development.--Not later than 15 months after the date 
        of the enactment of this Act, the Advisory Board shall develop 
        (with appropriate support from the Director and staff of the 
        Center) a comprehensive plan for the conduct and support of 
        liver disease research to be known as the Liver Disease 
        Research Action Plan. The Advisory Board shall submit the Plan 
        to the Director of NIH and the head of each institute or center 
        within the National Institutes of Health that funds liver 
        disease research.
            ``(2) Content.--The Liver Disease Research Action Plan 
        shall identify scientific opportunities and priorities of liver 
        disease research necessary to increase understanding of and to 
        prevent, cure, and develop better treatment protocols for liver 
        diseases.
            ``(3) Revision.--The Advisory Board shall revise every 3 
        years the Liver Disease Research Action Plan, but shall meet 
        annually to review progress and to amend the Plan as may be 
        appropriate because of new scientific discoveries.
    ``(f) Allocation of Funds.--Subject to the availability of 
appropriations, the Director of each institute or center within the 
National Institutes of Health shall allocate to liver disease research 
through peer-reviewed methods, the amounts necessary to fund existing 
scientific research opportunities and, subject to completion and 
subsequent updates of the Liver Disease Research Action Plan, amounts 
adequate to carry out the recommendations of the Plan.''.
answer:

Liver Research Enhancement Act - Amends the Public Health Service Act to establish the National Center on Liver Disease Research in the National Institute of Diabetes and Digestive and Kidney Diseases.Establishes the Liver Disease Research Advisory Board to help the Director of the Center develop the Liver Disease Research Action Plan identifying scientific opportunities and priorities of liver disease research. Requires the Director to coordinate the Plan's implementation by the national research institutes, which shall allocate adequate funds for same.